Related Experiment Video
Updated: May 5, 2026

Why Quantification Matters: Characterization of Phenotypes at the Drosophila Larval Neuromuscular Junction
Published on: May 12, 2016
The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control
Amina Moustaqim-Barrette1, Yong Q Lin, Sreeparna Pradhan
1Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal H3A 2B4 Canada.
Abstract:
A familial form of Amyotrophic lateral sclerosis (ALS8) is caused by a point mutation (P56S) in the vesicle-associated membrane protein associated protein B (VapB). Human VapB and Drosophila Vap-33-1 (Vap) are homologous type II transmembrane proteins that are localized to the ER. However, the precise consequences of the defects associated with the P56S mutation in the endoplasmic reticulum (ER) and its role in the pathology of ALS are not well understood. Here we show that Vap is required for ER protein quality control (ERQC). Loss of Vap in flies shows various ERQC associated defects, including protein accumulation, ER expansion, and ER stress. We also show that wild type Vap, but not the ALS8 mutant Vap, interacts with a lipid-binding protein, Oxysterol binding protein (Osbp), and that Vap is required for the proper localization of Osbp to the ER. Restoring the expression of Osbp in the ER suppresses the defects associated with loss of Vap and the ALS8 mutant Vap. Hence, we propose that the ALS8 mutation impairs the interaction of Vap with Osbp, resulting in hypomorphic defects that might contribute to the pathology of ALS8.
Insights
Amyotrophic lateral sclerosis (ALS8) is linked to VapB mutations, impacting ER protein quality control. Restoring Osbp function in the ER rescues these defects, suggesting a key role in ALS8 pathology.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease.
- Familial ALS (ALS8) is associated with mutations in the VapB gene.
- VapB is a transmembrane protein localized to the endoplasmic reticulum (ER).
Purpose of the Study:
- To investigate the role of VapB in ER protein quality control (ERQC).
- To understand the consequences of the ALS8-associated VapB mutation (P56S) in the ER.
- To elucidate the molecular mechanisms underlying ALS8 pathogenesis.
Main Methods:
- Utilized Drosophila melanogaster as a model organism.
- Assessed ERQC defects, including protein accumulation and ER stress.
- Investigated protein-protein interactions between VapB and Osbp using biochemical assays.
- Examined the localization of Osbp in the ER.
Main Results:
- Loss of Vap in flies leads to ERQC defects like protein accumulation and ER stress.
- Wild-type Vap, but not the ALS8 mutant Vap, interacts with Oxysterol binding protein (Osbp).
- Vap is essential for the correct ER localization of Osbp.
- Restoring Osbp expression in the ER rescues Vap loss- and ALS8 mutant Vap-associated defects.
Conclusions:
- Vap is crucial for ER protein quality control.
- The ALS8 mutation in VapB disrupts its interaction with Osbp.
- Impaired VapB-Osbp interaction leads to ER dysfunction and contributes to ALS8 pathology.
Related Concept Videos
Protein Folding Quality Check in the RER
Export of Misfolded Proteins out of the ER
The Unfolded Protein Response
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulation of the Unfolded Protein Response

